Paying Customers

15th April 2024

NTT DATA develops new AI solutions to detect and combat dementia and cognitive decline

Leading global innovator NTT DATA, and the wider NTT Group, has developed two new artificial intelligence (AI) solutions to help detect cognitive decline in elderly people. […]
15th April 2024

The right investment: How to efficiently implement Continuing Healthcare

With thanks to Jackie Gill, Product Manager at IEG4 for sharing her insight with Hospital Hub… When it comes to ensuring that people with complex health […]
15th April 2024

Patient on research study shares her story about the cancer ‘no one talks about’

Caroline Hyde (pictured top) was aware of bowel cancer. She’d followed Deborah James – also known as Bowel Babe – and her experience of being diagnosed, […]
10th April 2024

Somerset NHS Foundation Trust works with Oleeo to streamline recruitment

NHS trust is adopting new recruitment software to streamline processes, improve experience for managers and candidates, and address equality, diversity and inclusion Somerset NHS Foundation Trust […]
9th April 2024

Rinnai heat pumps, continuous flow water heaters and boilers will be used as training equipment at Stockport College

Stockport College have recently completed a £25M campus redevelopment programme to ensure that all courses have the highest standards of facilities and resources. The college also […]
8th April 2024

Reducing caesarean section surgical site infections

April is International Caesarean Awareness Month and in 2023 in England 42% of deliveries were by Caesarean section (CS) [NHS digital, 2024], compared to just 9% […]
4th April 2024

Revolutionary non-invasive neurostimulation technology for chronic insomnia showcased at CMEF 2024

A pioneering non-invasive neurostimulation technology for chronic insomnia will be showcased on the ABHI UK Pavilion at CMEF 2024, offering a glimpse into the future of […]
4th April 2024

The risks of high cholesterol

High cholesterol is a common health condition affecting millions of people. It occurs when excessive cholesterol is in the blood, leading to serious health risks if […]
2nd April 2024

Great Britain is first across Europe to get regulatory approval of MAVENCLAD® (cladribine tablets) as the only short course oral treatment for active Relapsing Multiple Sclerosis patients

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved an expanded label for MAVENCLAD® (cladribine tablets), now indicated for the treatment of adult patients with […]